Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Waverley Pharma Inc
V.WAVE
Healthcare
Biotechnology
Waverley Pharma Inc. is a biopharmaceutical company engaged in the research, development, and commercialization of human therapeutics focused on oncology. The Company is focused on the generic oncology injectable market in Europe, the United Kingdom (UK), and North America. The Company, through its subsidiaries, has entered into a license, manufacture, supply, marketing and distribution...
agreement with Reliance Life Sciences Private Limited, which has granted the Company an exclusive territorial license to market and sell capecitabine in the UK and Germany as well as a non-exclusive territorial license to market and sell temozolomide and erlotinib in the UK. Its generic oncology products include bortezomib and pemetrexed. Bortezomib is an injectable generic chemotherapy drug, developed for the treatment of multiple myeloma and mantle cell lymphoma. Pemetrexed is an injectable generic chemotherapy drug, developed for the treatment of non-small cell lung cancer and pleural mesothelioma.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:WAVE)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(23)
•••
Johnmeco
X
View Profile
View Bullboard History
Post by
Johnmeco
on Jul 07, 2022 8:24pm
Pemetrexed
Waverley pharma's pemetrexed sold at drugs.com from May 25th Generic Alimta Availability - Drugs.com - https://www.drugs.com/availability/generic-alimta.html
(251)
•••
bigstar10
X
View Profile
View Bullboard History
Post by
bigstar10
on Jul 04, 2022 10:01am
??
Aurelio ?????
(23)
•••
Johnmeco
X
View Profile
View Bullboard History
Post by
Johnmeco
on Apr 12, 2022 9:36pm
Notice of the meeting and record date
https://www.sedar.com/DisplayCompanyDocuments.do?lang=EN&issuerNo=00042362 Do you what this notice means? Is the record date where they determine which shareholders are eligible to receive
...more
(23)
•••
Johnmeco
X
View Profile
View Bullboard History
Post by
Johnmeco
on Mar 16, 2022 6:19pm
Today's Europe market
Not much volume but what happen European market today...
(23)
•••
Johnmeco
X
View Profile
View Bullboard History
Comment by
Johnmeco
on Feb 15, 2022 6:39pm
RE:After 6 months
I first bought this one 2 years ago and kept buying almost every month. I lost over 20k so far but I can wait a couple more years and will get great fruits.
(23)
•••
Johnmeco
X
View Profile
View Bullboard History
Post by
Johnmeco
on Feb 15, 2022 6:19pm
After 6 months
European market is just warming up, USA market is totally different. Dr. Friesen said European market is small and very low price but USA market is much higher volumes and much better pricing
...more
(251)
•••
bigstar10
X
View Profile
View Bullboard History
Comment by
bigstar10
on Feb 15, 2022 10:44am
RE:Email from Dr. Friesen
Sweet!!!!
(23)
•••
Johnmeco
X
View Profile
View Bullboard History
Post by
Johnmeco
on Feb 04, 2022 11:47am
Email from Dr. Friesen
This is copy from yahoo Isaac's post From Dr. Friesen Both Pemetrexed and Bortezomib are scheduled for approval this summer. Waverley Pharma is presently working with GPOs and other buying groups
...more
(251)
•••
bigstar10
X
View Profile
View Bullboard History
Comment by
bigstar10
on Dec 02, 2021 9:01am
RE:RE:Q3 financial report on sedar
Cash funding in place low share count!!! Just need rollout!
(4)
•••
alfhope
X
View Profile
View Bullboard History
Comment by
alfhope
on Nov 27, 2021 10:01am
RE:Q3 financial report on sedar
What is new in your opinion?
(23)
•••
Johnmeco
X
View Profile
View Bullboard History
Post by
Johnmeco
on Nov 26, 2021 4:41pm
Q3 financial report on sedar
Also, Please check MD&A page 8 "Product development"
(251)
•••
bigstar10
X
View Profile
View Bullboard History
Post by
bigstar10
on Nov 21, 2021 8:34pm
Ready to rock!
Do your own dd!!!
(251)
•••
bigstar10
X
View Profile
View Bullboard History
Comment by
bigstar10
on Nov 07, 2021 7:54pm
RE:RE:Financials
Better be good financials or could get ugly, I'm buying more at .105
(18)
•••
Investor62
X
View Profile
View Bullboard History
Comment by
Investor62
on Nov 06, 2021 6:27am
RE:Financials
let's hope as this is a bit a black box. On May 27th they announced the successful tender in the UK for the exclusive distribution rights for two strengths of pemetrexed (100mg and 500mg) by
...more
(251)
•••
bigstar10
X
View Profile
View Bullboard History
Post by
bigstar10
on Nov 04, 2021 8:31am
Financials
Should be a good quarter to spike s/p
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
An Opportunity to Join Pulsar Helium on the Ground in Minnesota for a Historic Reservoir Flow Test
Significant New Silver Discoveries in the Famous Keno Hill District in the Yukon